Expression of hyaluronan in benign and malignant breast lesions

被引:0
作者
Auvinen, PK
Parkkinen, JJ
Johansson, RT
Agren, UM
Tammi, RH
Eskelinen, MJ
Kosma, VM
机构
[1] KUOPIO UNIV HOSP, DEPT PATHOL, SF-70210 KUOPIO, FINLAND
[2] UNIV KUOPIO, DEPT PATHOL & FORENS MED, FIN-70211 KUOPIO, FINLAND
[3] UNIV KUOPIO, DEPT ANAT, FIN-70211 KUOPIO, FINLAND
[4] KUOPIO UNIV HOSP, DEPT SURG, SF-70210 KUOPIO, FINLAND
关键词
D O I
10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.0.CO;2-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hyaluronan (HA) is one of the extracellular-matrix components involved in wound healing, tumour growth and metastasis, Due to the limited data on HA expression in benign and malignant breast lesions, we analyzed its presence in these lesions by using the biotinylated-hyaluronan-binding region and the link-protein complex (bHABC) of cartilage proteoglycan as a specific probe. In all benign breast lesions, the expression of HA was restricted to the stromal connective tissue, the ductal epithelial cells being completely devoid of HA. In malignant breast tumours, the intensity of stromal HA staining was significantly stronger than in benign lesions. In addition, HA was detected on cell membranes or in cytoplasms of adenocarcinoma cells, in some cases of ductal carcinoma in situ and in 31% of malignant tumours, The staining pattern was mostly similar in all breast-cancer types studied, i.e., ductal, lobular, tubular, mucinous and medullary, In ductal breast cancer, intense HA expression in stroma and carcinoma cells correlated statistically significantly to poor differentation of carcinoma, suggesting that altered HA expression may affect the mechanisms of breast-cancer progression. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 20 条
[1]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]   HYALURONAN (HYALURONIC-ACID) AND HYALURONECTIN IN THE EXTRACELLULAR-MATRIX OF HUMAN BREAST CARCINOMAS - COMPARISON BETWEEN INVASIVE AND NONINVASIVE AREAS [J].
BERTRAND, P ;
GIRARD, N ;
DELPECH, B ;
DUVAL, C ;
DANJOU, J ;
DAUCE, JP .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (01) :1-6
[3]  
CATERSON B, 1985, FED PROC, V44, P386
[4]   BINDING AND DEGRADATION OF HYALURONAN BY HUMAN BREAST-CANCER CELL-LINES EXPRESSING DIFFERENT FORMS OF CD44 - CORRELATION WITH INVASIVE POTENTIAL [J].
CULTY, M ;
SHIZARI, M ;
THOMPSON, EW ;
UNDERHILL, CB .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 160 (02) :275-286
[5]   COMPARISON OF IMMUNOHISTOCHEMISTRY AND RT-PCR FOR DETECTION OF CD44V-EXPRESSION, A NEW PROGNOSTIC FACTOR IN HUMAN BREAST-CANCER [J].
DALL, P ;
HEIDER, KH ;
SINN, HP ;
SKROCHANGEL, P ;
ADOLF, G ;
KAUFMANN, M ;
HERRLICH, P ;
PONTA, H .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (04) :471-477
[6]   LOCALIZATION OF HYALURONAN IN NORMAL BREAST-TISSUE, RADIAL SCAR, AND TUBULAR BREAST-CARCINOMA [J].
DELATORRE, M ;
WELLS, AF ;
BERGH, J ;
LINDGREN, A .
HUMAN PATHOLOGY, 1993, 24 (12) :1294-1297
[7]   MOLECULAR-CLONING OF A NOVEL HYALURONAN RECEPTOR THAT MEDIATES TUMOR-CELL MOTILITY [J].
HARDWICK, C ;
HOARE, K ;
OWENS, R ;
HOHN, HP ;
HOOK, M ;
MOORE, D ;
CRIPPS, V ;
AUSTEN, L ;
NANCE, DM ;
TURLEY, EA .
JOURNAL OF CELL BIOLOGY, 1992, 117 (06) :1343-1350
[8]  
JOENSUU H, 1993, AM J PATHOL, V143, P867
[9]  
KIMATA K, 1983, CANCER RES, V43, P1347
[10]  
KNUDSON W, 1989, CIBA F SYMP, V143, P150